SILAC-Based Mass Spectrometry Analysis Reveals That Epibrassinolide Induces Apoptosis via Activating Endoplasmic Reticulum Stress in Prostate Cancer Cells.
Epibrassinolide (EBR) is a polyhydroxylated sterol derivative and biologically active compound of the brassinosteroids. In addition to well-described roles in plant growth, EBR induces apoptosis in the LNCaP prostate cancer cells expressing functional androgen receptor (AR). Therefore, it is suggested that EBR might have an inhibitory potential on androgen receptor signaling pathway. However, the mechanism by which EBR exerts its effects on LNCaP is poorly understood. To address this gap in knowledge, we used an unbiased global proteomics approach, i.e., stable-isotope labeling by amino acids in cell culture (SILAC). In total, 964 unique proteins were identified, 160 of which were differentially expressed after 12 h of EBR treatment. The quantification of the differentially expressed proteins revealed that the expression of the unfolded protein response (UPR) chaperone protein, calreticulin (CALR), was dramatically downregulated. The decrease in CALR expression was also validated by immunoblotting. Because our data revealed the involvement of the UPR in response to EBR exposure, we evaluated the expression of the other UPR proteins. We demonstrated that EBR treatment downregulated calnexin and upregulated BiP and IRE1α expression levels and induced CHOP translocation from the cytoplasm to nucleus. The translocation of CHOP was associated with caspase-9 and caspase-3 activation after a 12 h EBR treatment. Co-treatment of EBR with rapamycin, an upstream mTOR pathway inhibitor, prevented EBR-induced cell viability loss and PARP cleavage in LNCaP prostate cancer cells, suggesting that EBR could induce ER stress in these cells. In addition, we observed similar results in DU145 cells with nonfunctional androgen receptor. When proteasomal degradation of proteins was blocked by MG132 co-treatment, EBR treatment further induced PARP cleavage relative to drug treatment alone. EBR also induced Ca2+ sequestration, which confirmed the alteration of the ER pathway due to drug treatment. Therefore, we suggest that EBR promotes ER stress and induces apoptosis.
Istanbul Kultur University, Department of Molecular Biology and Genetics, Atakoy Campus, Bakirkoy, Istanbul-Turkey.
Pinar
P
Obakan
Department of Biochemistry, Temple University School of Medicine, Fels Institute, 3307 N. Broad Street, Philadelphia, Pennsylvania, United States of America.
Carlos
C
Barrero
Istanbul Kultur University, Department of Molecular Biology and Genetics, Atakoy Campus, Bakirkoy, Istanbul-Turkey.
Ajda
A
Coker-Gurkan
Istanbul Kultur University, Department of Molecular Biology and Genetics, Atakoy Campus, Bakirkoy, Istanbul-Turkey.
Elif Damla
ED
Arisan
Department of Biochemistry, Temple University School of Medicine, Fels Institute, 3307 N. Broad Street, Philadelphia, Pennsylvania, United States of America.
Salim
S
Merali
Istanbul Kultur University, Department of Molecular Biology and Genetics, Atakoy Campus, Bakirkoy, Istanbul-Turkey.
Narcin
N
Palavan-Unsal
D000972:Antineoplastic Agents, Phytogenic / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects*; D060406:Brassinosteroids / Q000494:pharmacology*; D045744:Cell Line, Tumor; D059865:Endoplasmic Reticulum Stress / Q000187:drug effects*; D006801:Humans; D008297:Male; D013058:Mass Spectrometry; D011467:Prostate / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D020543:Proteome / Q000378:metabolism; D013260:Steroids, Heterocyclic / Q000494:pharmacology*
D000972:Antineoplastic Agents, Phytogenic; D060406:Brassinosteroids; D020543:Proteome; D013260:Steroids, Heterocyclic; C023623:brassinolide